title: p53 expression in human carotid atheroma is significantly related to plaque instability and clinical manifestations.
abstract: OBJECTIVE
  The expression of p53 has been associated with DNA damage, cell senescence, proliferation and apoptosis in human atherosclerotic plaques. However, it is largely unknown whether p53 expression is related to the stability and clinical manifestations of atherosclerotic plaques in humans. In the present study, we examined whether p53 expression is related to clinical symptoms and plaque integrity in patients with carotid atherosclerosis (n=62). We also investigated p53 expression and its relation to apoptosis and apoptosis-related cathepsin L and ferritin in the carotid lesions.
  
  
  RESULTS
  We found that smooth muscle cells often had nuclear p53 in the shoulder region of carotid lesions while CD68-positive macrophages, which had both nuclear and cytoplasmic p53, frequently appeared in the surrounding areas of necrotic cores or plaque cap regions. Quantitative image analysis of immunohistochemistry showed that p53 expression was significantly increased in plaques with necrotic core formation or cap rupture and lesions from patients with transient ischemic attacks (TIAs). The levels of p53 expression was significantly increased in more severe stenosed lesions but decreased with prolonged time between symptom onset and carotid endarterectomy. Furthermore, p53 expression was significantly correlated with the expression of ferritin, lysosomal cathepsin L, and apoptosis.
  
  
  CONCLUSIONS
  The increased p53 expression, particularly macrophage p53 levels, is associated with the enlargement of necrotic cores, plaque rupture and clinical manifestations of carotid plaques. Concomitant increases of lysosomal cathepsin, ferritin, and p53 levels may promote the apoptosis and atheroma progression in patients with carotid atherosclerosis.
authors.affiliation: Division of Experimental Pathology, Department of Clinical and Experimental Medicine, Faculty of Health Sciences, Linköping University, Linköping SE-581 85, Sweden. ximing.yuan@liu.se
authors.forename: Xi-Ming
authors.initials: XM
authors.lastname: Yuan
authors.forename: Ehab
authors.initials: E
authors.lastname: Osman
authors.forename: Sayem
authors.initials: S
authors.lastname: Miah
authors.forename: Shahram Nour Mohammad
authors.initials: SN
authors.lastname: Zadeh
authors.forename: Lihua
authors.initials: L
authors.lastname: Xu
authors.forename: Claes
authors.initials: C
authors.lastname: Forssell
authors.forename: Wei
authors.initials: W
authors.lastname: Li
mesh_terms: D000368:Aged; D017209:Apoptosis; D056668:Cathepsin L / Q000378:metabolism; D016922:Cellular Senescence; D004249:DNA Damage; D005260:Female; D005293:Ferritins / Q000737:chemistry / Q000378:metabolism; D016158:Genes, p53; D006801:Humans; D008247:Lysosomes / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D058226:Plaque, Atherosclerotic / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*
chemical_list: D016159:Tumor Suppressor Protein p53; D005293:Ferritins; D056668:Cathepsin L